Related references
Note: Only part of the references are listed.Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro
Mikhail Burmakin et al.
CLINICAL CANCER RESEARCH (2013)
Targeting p53 by small molecules in hematological malignancies
Manujendra N. Saha et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
Manujendra N. Saha et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma
Manujendra N. Saha et al.
PLOS ONE (2012)
PRIMA-1Met/APR-246 induces wild-type p53-dependent suppression of malignant melanoma tumor growth in 3D culture and in vivo
Wenjie Bao et al.
CELL CYCLE (2011)
Oncogenomics to Target Myeloma in the Bone Marrow Microenvironment
Kenneth C. Anderson
CLINICAL CANCER RESEARCH (2011)
In Vitro and In Vivo Selective Antitumor Activity of a Novel Orally Bioavailable Proteasome Inhibitor MLN9708 against Multiple Myeloma Cells
Dharminder Chauhan et al.
CLINICAL CANCER RESEARCH (2011)
Emerging therapies for the treatment of relapsed or refractory multiple myeloma
Meletios A. Dimopoulos et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Resveratrol Induces p53-independent, X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Bax Protein Oligomerization on Mitochondria to Initiate Cytochrome c Release and Caspase Activation
Raghu Gogada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro
Jiabei Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma Evidence for p53-transcription-dependent and -independent pathways
Manujendra N. Saha et al.
CANCER BIOLOGY & THERAPY (2010)
Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA
Carolyn Y. Zhao et al.
CELL CYCLE (2010)
Pharmacological activation of the p53 pathway in haematological malignancies
Manujendra N. Saha et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
RITA Inhibits Multiple Myeloma Cell Growth through Induction of p53-Mediated Caspase-Dependent Apoptosis and Synergistically Enhances Nutlin-Induced Cytotoxic Responses
Manujendra N. Saha et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
Constantine S. Mitsiades et al.
SEMINARS IN HEMATOLOGY (2009)
Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress
Chen Chen Jiang et al.
CANCER RESEARCH (2008)
Restoration of p53 to limit tumor growth
Wenge Wang et al.
CURRENT OPINION IN ONCOLOGY (2008)
PRIMA-1met radiosensitizes prostate cancer cells independent of their MTp53-status
Stephane Supiot et al.
RADIOTHERAPY AND ONCOLOGY (2008)
6-hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA
Maria Gomez-Lazaro et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma
Patricia Gomez-Bougie et al.
CANCER RESEARCH (2007)
Strategies for therapeutic targeting of the p53 pathway in cancer
K. G. Wiman
CELL DEATH AND DIFFERENTIATION (2006)
Endoplasmic reticulum stress-induced apoptosis - Multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53
JZ Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs
VJN Bykov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
4-hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-Myc, up-regulation of p27KiP1, and modulation of Bcl-2 family members
J Gauduchon et al.
CLINICAL CANCER RESEARCH (2005)
p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation
H Chang et al.
BLOOD (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
JR Jeffers et al.
CANCER CELL (2003)
Myeloid cell factor-1 is a critical survival factor for multiple myeloma
B Zhang et al.
BLOOD (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
Share Paper
